Could turn out to be a brilliant decision for the both of us and everyone else then.
The CRL might be re-issued assuming the label is correct, in light of new information.
The only new information is the results of the HF trial. Now we expect this to be straight forward given the result was 100% used the product correctly, however FDA might take issue with the number or the way the HF trial was conducted. Just putting it out there, it could happen. Its extremely unlikely IMO the trial would have had to been conducted by amateurs for this scale of error , but possible never the less. That is my only doubt, and its balanced against the large number of treatments the team have successfully bought to market, makes me think they must know what they are doing.
Could turn out to be a brilliant decision for the both of us and...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $472.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.3¢ | $824.2K | 2.803M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 406362 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 290048 | 6 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.5¢ |
Change
0.010 ( 5.28 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 30.5¢ | 28.0¢ | 960021 | ||
| Last updated 15.58pm 24/05/2024 ? | |||||
| BOT (ASX) Chart |